This approval marks a milestone for high-risk sMM patients, but analyst Biswajit Podder notes that there are caveats to its ...

For many people, neuropathy feels like a life sentence of pain. The burning, tingling, and numbness in the feet and legs make ...

Akeso, Inc. (HKEX: 9926.HK) published the preclinical research data for its novel antagonistic monoclonal antibody targeting IL-1RAP, AK135, at the 40th Annual Meeting of the Society for Immunotherapy ...

Learn more about whether BioMarin Pharmaceutical Inc. or Halozyme Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

The approval for HR-SMM was based on data from the phase 3 AQUILA study, which evaluated Darzalex Faspro in adults aged 31 years and older with HR-SMM.

Leaders and believers from different faiths gather every Sunday at the gates of the Florida detention center to show their ...

Learn more about whether Halozyme Therapeutics, Inc. or Viridian Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

The post Groundbreaking Stem Cell Trial For Those With Hearing Loss Approved In The UK first on TwistedSifter. According to ...

Public interest has recently turned to the human eye and the Pfizer COVID-19 Vaccine. Two peer-reviewed papers have helped ...

Check out our weekly list of new fundraisers from Lend A Hand Up, a nonprofit crowdfunding site supporting families in Cass, ...

Johnson & Johnson secures FDA approval for Darzalex Faspro as the first and only treatment for adults with high-risk smoldering multiple myeloma, supported by Phase III Aquila trial data showing a 51% ...

Columnist Sherry Toh can't fathom generative AI replacing human empathy when it comes to caregiving for people with rare diseases.